Skip to main content
Fig. 1 | Critical Care

Fig. 1

From: Effects of levosimendan on occurrence of cerebral vasospasm after aneurysmal subarachnoid hemorrhage: a case–control study

Fig. 1

Mean vessels diameters variations between day 1 and days 5–7 in levosimendan treated vs control patients. Quantitative analysis of cerebral arteries diameters in patients who had vessel imaging (CT or angiography) at admission and at days 5–7 in nine levosimendan-treated patients and 18 controls. Vessels narrowing was more pronounced in controls compared to levosimendan-treated patients (P = 0.004)

Back to article page

Critical Care

ISSN: 1364-8535